Abstract
Background Pharmaceutical expenses keep exerting pressure on health expenditures across Europe. A common strategy to stimulate the use of cheaper medicines is generic substitution and the use of the International Non-proprietary Name (INN) in medicine prescribing. Since 2006, Belgian physicians have to reach a minimum of ‘cheap’ prescriptions per year (including INN prescriptions). INN prescribing can result in considerable savings for patient and health insurance in Belgium. Since …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
